Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Disease, Chronic Obstructive | 23 | 2024 | 3252 | 2.570 |
Why?
|
Pulmonary Emphysema | 5 | 2024 | 689 | 1.410 |
Why?
|
Idiopathic Pulmonary Fibrosis | 5 | 2024 | 521 | 1.140 |
Why?
|
Lung | 15 | 2024 | 10099 | 0.880 |
Why?
|
Eosinophils | 2 | 2018 | 952 | 0.860 |
Why?
|
Pulmonary Eosinophilia | 1 | 2019 | 78 | 0.640 |
Why?
|
Respiration Disorders | 1 | 2022 | 364 | 0.630 |
Why?
|
Forced Expiratory Volume | 3 | 2022 | 1831 | 0.620 |
Why?
|
Lymphocytes | 1 | 2021 | 2614 | 0.430 |
Why?
|
Membrane Glycoproteins | 2 | 2021 | 3711 | 0.420 |
Why?
|
Emphysema | 4 | 2024 | 236 | 0.380 |
Why?
|
Carrier Proteins | 2 | 2021 | 4937 | 0.350 |
Why?
|
Gene Expression Profiling | 6 | 2024 | 9538 | 0.350 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2007 | 52 | 0.290 |
Why?
|
RNA Viruses | 1 | 2008 | 112 | 0.280 |
Why?
|
Gene Expression Regulation | 3 | 2022 | 11928 | 0.270 |
Why?
|
Leukocyte Count | 3 | 2018 | 1609 | 0.260 |
Why?
|
Vitamin B Complex | 1 | 2007 | 299 | 0.250 |
Why?
|
alpha 1-Antitrypsin | 2 | 2024 | 169 | 0.240 |
Why?
|
Leukemia Inhibitory Factor | 1 | 2024 | 81 | 0.230 |
Why?
|
BCG Vaccine | 1 | 2007 | 381 | 0.230 |
Why?
|
Vitamin A | 1 | 2007 | 611 | 0.230 |
Why?
|
Tobacco Smoke Pollution | 2 | 2021 | 828 | 0.230 |
Why?
|
Smoking | 4 | 2021 | 9092 | 0.220 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2024 | 113 | 0.220 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2023 | 192 | 0.210 |
Why?
|
Fibroblasts | 2 | 2024 | 4176 | 0.200 |
Why?
|
Inflammation | 2 | 2023 | 10873 | 0.200 |
Why?
|
Interleukin-13 | 1 | 2024 | 390 | 0.200 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2024 | 638 | 0.180 |
Why?
|
Desmoplakins | 1 | 2020 | 63 | 0.180 |
Why?
|
Folic Acid | 1 | 2007 | 1337 | 0.180 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4648 | 0.170 |
Why?
|
Vitamins | 1 | 2007 | 1638 | 0.160 |
Why?
|
Interferons | 1 | 2022 | 720 | 0.150 |
Why?
|
GTPase-Activating Proteins | 1 | 2021 | 467 | 0.150 |
Why?
|
Genome-Wide Association Study | 4 | 2021 | 12795 | 0.150 |
Why?
|
F-Box Proteins | 1 | 2019 | 199 | 0.140 |
Why?
|
Molecular Epidemiology | 1 | 2019 | 473 | 0.140 |
Why?
|
Disease Progression | 5 | 2023 | 13671 | 0.140 |
Why?
|
Xenobiotics | 1 | 2017 | 71 | 0.140 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2008 | 3514 | 0.140 |
Why?
|
Genotype | 2 | 2022 | 13045 | 0.140 |
Why?
|
Adenoma | 1 | 2007 | 2159 | 0.140 |
Why?
|
Sequence Analysis, RNA | 3 | 2022 | 2040 | 0.130 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2023 | 617 | 0.130 |
Why?
|
Phenotype | 5 | 2022 | 16726 | 0.130 |
Why?
|
Signal Transduction | 3 | 2024 | 23645 | 0.130 |
Why?
|
Exons | 2 | 2019 | 2394 | 0.120 |
Why?
|
RNA | 2 | 2023 | 2720 | 0.120 |
Why?
|
Heterozygote | 1 | 2022 | 2798 | 0.120 |
Why?
|
Spirometry | 1 | 2018 | 929 | 0.120 |
Why?
|
Haploinsufficiency | 1 | 2016 | 334 | 0.110 |
Why?
|
Alternative Splicing | 1 | 2019 | 1105 | 0.110 |
Why?
|
RNA, Untranslated | 1 | 2017 | 455 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 6 | 2022 | 18065 | 0.110 |
Why?
|
Gene Expression | 3 | 2021 | 7598 | 0.110 |
Why?
|
Humans | 35 | 2024 | 768166 | 0.110 |
Why?
|
Adaptive Immunity | 1 | 2018 | 733 | 0.100 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2540 | 0.100 |
Why?
|
Hepatitis C | 1 | 2023 | 1595 | 0.100 |
Why?
|
Disease Models, Animal | 3 | 2023 | 18349 | 0.100 |
Why?
|
Respiratory Function Tests | 3 | 2022 | 1695 | 0.100 |
Why?
|
Mice, Knockout | 3 | 2021 | 14488 | 0.100 |
Why?
|
Immunity, Innate | 2 | 2018 | 3080 | 0.100 |
Why?
|
Severity of Illness Index | 3 | 2024 | 15948 | 0.090 |
Why?
|
Leukocytes | 1 | 2018 | 2035 | 0.080 |
Why?
|
Endocarditis, Bacterial | 1 | 2013 | 436 | 0.080 |
Why?
|
Venous Thromboembolism | 2 | 2014 | 1883 | 0.080 |
Why?
|
Mice, Inbred C57BL | 4 | 2021 | 22379 | 0.080 |
Why?
|
Endocarditis | 1 | 2013 | 352 | 0.080 |
Why?
|
Renin-Angiotensin System | 1 | 2014 | 737 | 0.080 |
Why?
|
Oxidative Stress | 2 | 2017 | 3139 | 0.080 |
Why?
|
Aged | 13 | 2024 | 171504 | 0.080 |
Why?
|
Oxygen | 2 | 2018 | 4270 | 0.080 |
Why?
|
Stem Cells | 1 | 2021 | 3537 | 0.080 |
Why?
|
Gambia | 1 | 2007 | 104 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2744 | 0.070 |
Why?
|
Colorectal Neoplasms | 1 | 2007 | 6974 | 0.070 |
Why?
|
Sepsis | 1 | 2021 | 2608 | 0.070 |
Why?
|
Animals | 9 | 2023 | 169246 | 0.070 |
Why?
|
Models, Genetic | 1 | 2017 | 3447 | 0.070 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 1515 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2008 | 379 | 0.070 |
Why?
|
Asthma | 2 | 2021 | 6291 | 0.070 |
Why?
|
Male | 17 | 2024 | 364719 | 0.070 |
Why?
|
Middle Aged | 12 | 2024 | 223492 | 0.070 |
Why?
|
Tachycardia, Ventricular | 1 | 2015 | 1309 | 0.060 |
Why?
|
Chronic Disease | 2 | 2019 | 9384 | 0.060 |
Why?
|
Mice | 6 | 2023 | 82029 | 0.060 |
Why?
|
Cells, Cultured | 1 | 2021 | 19015 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2022 | 14783 | 0.060 |
Why?
|
Genetic Variation | 1 | 2020 | 6611 | 0.060 |
Why?
|
Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2024 | 30 | 0.060 |
Why?
|
Female | 16 | 2024 | 397192 | 0.060 |
Why?
|
Morphogenesis | 1 | 2008 | 746 | 0.060 |
Why?
|
Myofibroblasts | 1 | 2024 | 230 | 0.050 |
Why?
|
Drug Interactions | 1 | 2007 | 1419 | 0.050 |
Why?
|
Virus Diseases | 1 | 2008 | 724 | 0.050 |
Why?
|
Electrocardiography | 1 | 2015 | 6412 | 0.050 |
Why?
|
Janus Kinase 2 | 1 | 2024 | 561 | 0.050 |
Why?
|
Interleukin-4 | 1 | 2024 | 1156 | 0.040 |
Why?
|
Atherosclerosis | 2 | 2014 | 3433 | 0.040 |
Why?
|
Hypertension, Pulmonary | 2 | 2008 | 1605 | 0.040 |
Why?
|
Risk Assessment | 1 | 2022 | 24315 | 0.040 |
Why?
|
Proteomics | 2 | 2024 | 3912 | 0.040 |
Why?
|
Aspirin | 2 | 2011 | 3135 | 0.040 |
Why?
|
Arylsulfotransferase | 1 | 2019 | 27 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2022 | 59629 | 0.040 |
Why?
|
Myocardial Infarction | 3 | 2015 | 11519 | 0.040 |
Why?
|
Mutation | 1 | 2023 | 30238 | 0.040 |
Why?
|
Neoplasms | 1 | 2007 | 22371 | 0.040 |
Why?
|
Sex Factors | 2 | 2013 | 10632 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2271 | 0.040 |
Why?
|
Lung Diseases | 1 | 2007 | 1944 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2023 | 1082 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3251 | 0.030 |
Why?
|
Glutathione S-Transferase pi | 1 | 2016 | 99 | 0.030 |
Why?
|
HIV Infections | 1 | 2023 | 17569 | 0.030 |
Why?
|
Lung Compliance | 1 | 2016 | 207 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2019 | 663 | 0.030 |
Why?
|
Hepacivirus | 1 | 2023 | 1344 | 0.030 |
Why?
|
Genetic Markers | 1 | 2022 | 2603 | 0.030 |
Why?
|
Risk | 1 | 2007 | 9613 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2008 | 3589 | 0.030 |
Why?
|
Acetylcysteine | 1 | 2016 | 262 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1793 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2568 | 0.030 |
Why?
|
RNA, Viral | 1 | 2023 | 2872 | 0.030 |
Why?
|
Glutathione | 1 | 2016 | 589 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2022 | 15454 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2022 | 1422 | 0.030 |
Why?
|
Philadelphia | 1 | 2013 | 271 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1469 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2019 | 2732 | 0.030 |
Why?
|
Computational Biology | 1 | 2024 | 3568 | 0.030 |
Why?
|
Models, Biological | 1 | 2008 | 9495 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2019 | 2131 | 0.020 |
Why?
|
Risk Factors | 3 | 2022 | 74944 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2007 | 26422 | 0.020 |
Why?
|
Odds Ratio | 1 | 2022 | 9669 | 0.020 |
Why?
|
Survival Analysis | 1 | 2022 | 10101 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2020 | 3703 | 0.020 |
Why?
|
Age Factors | 2 | 2016 | 18412 | 0.020 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 1 | 2008 | 221 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 54926 | 0.020 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2007 | 193 | 0.020 |
Why?
|
Ticlopidine | 1 | 2011 | 730 | 0.020 |
Why?
|
Cerebral Infarction | 1 | 2011 | 969 | 0.020 |
Why?
|
Pulmonary Gas Exchange | 1 | 2007 | 389 | 0.020 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2007 | 239 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3533 | 0.020 |
Why?
|
Infant | 1 | 2007 | 36535 | 0.020 |
Why?
|
Pulmonary Circulation | 1 | 2007 | 745 | 0.010 |
Why?
|
Risk Reduction Behavior | 1 | 2011 | 1119 | 0.010 |
Why?
|
Incidence | 2 | 2013 | 21538 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2022 | 22291 | 0.010 |
Why?
|
Population Surveillance | 1 | 2013 | 2596 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2013 | 2784 | 0.010 |
Why?
|
Genomics | 1 | 2018 | 5926 | 0.010 |
Why?
|
Transcription Factors | 1 | 2022 | 12168 | 0.010 |
Why?
|
Telomere | 1 | 2008 | 944 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2011 | 6316 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6526 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2014 | 3007 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2008 | 2219 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39348 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16045 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2013 | 5349 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2011 | 2763 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10760 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2011 | 2599 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 30010 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12543 | 0.010 |
Why?
|
Time Factors | 1 | 2018 | 40218 | 0.010 |
Why?
|
Adult | 2 | 2022 | 223646 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2014 | 81762 | 0.010 |
Why?
|
Stroke | 1 | 2014 | 9755 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 26379 | 0.010 |
Why?
|
Cohort Studies | 1 | 2011 | 41754 | 0.000 |
Why?
|
Concepts
(180)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(49)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_